Evolent Health Inc Revenue Growth Rates (EVH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Evolent Health Inc   (NYSE: EVH)
 

EVH's Revenue Growth by Quarter and Year

Evolent Health Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/EVH/growth
https://api.csimarket.com/api/v1/companies/EVH/fundamentals
https://api.csimarket.com/api/v1/companies/EVH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
EVH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 725.37
2nd Quarter June 652.52
1st Quarter March 496.25
FY 1,874.14

EVHs Annual Revenue
Evolent Health Inc 's Revenue in the fiscal year 2025 $ 1,876.23 millions
Evolent Health Inc 's Revenue in the fiscal year 2024 $ 2,554.74 millions
Evolent Health Inc 's Revenue in the fiscal year 2023 $ 1,963.90 millions
Evolent Health Inc 's Revenue in the fiscal year 2022 $ 1,352.01 millions
Evolent Health Inc 's Revenue in the fiscal year 2021 $ 907.96 millions




EVH Revenue third quarter 2026 Y/Y Growth Comment
Evolent Health Inc achieved in the third quarter 2026, above Company average Revenue rise of 51.27% year on year, to $ 725.37 millions.

According to the results reported in the third quarter 2026, Evolent Health Inc achieved the best Revenue growth in Internet Services & Social Media industry. While Evolent Health Inc ' s Revenue jump of 51.27% ranks overall at the positon no. 489 in the third quarter 2026.


EVH Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 51.27 %
2nd Quarter June 46.85 %
1st Quarter March 2.61 %
FY   -

Financial Statements
Evolent Health Inc 's third quarter 2026 Revenue $ 725.37 millions EVH's Income Statement
Evolent Health Inc 's third quarter 2025 Revenue $ 479.53 millions Quarterly EVH's Income Statement


EVH Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 11.16 %
2nd Quarter June 31.49 %
1st Quarter March 5.87 %
FY (Year on Year)   -


Back to EVH Growth rate Comparisons >> Back to EVH Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Internet Services & Social Media Industry #1
Technology Sector #91
Overall #489

Revenue Y/Y Growth Statistics
High Average Low
442.71 % 39.05 % -34.24 %
(Mar 31 2017)   (Dec 31 2018)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Internet Services & Social Media Industry #1
Technology Sector #91
Overall #489
Revenue Y/Y Growth Statistics
High Average Low
442.71 % 39.05 % -34.24 %
(Mar 31 2017)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Evolent Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
288 % 13.46 % -43.01 %
(Sep 30 2015)  


EVH's III. Quarter Q/Q Revenue Comment
Evolent Health Inc achieved in the III. Quarter 2026 below company average Revenue rise of 11.16% quarter on quarter, to $ 725.37 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 7.92% in the III. Quarter a year ago.

Within Internet Services & Social Media industry Evolent Health Inc achieved highest sequential Revenue growth. While Evolent Health Inc 's Revenue growth quarter on quarter, overall rank is 359.


Revenue Q/Q Growth Company Ranking
Within: No.
Internet Services & Social Media Industry #1
Technology Sector #45
Overall #359
Revenue Q/Q Growth Company Ranking
Within: No.
Internet Services & Social Media Industry #1
Technology Sector #45
Overall #359
Revenue Q/Q Growth Statistics
High Average Low
288 % 13.46 % -43.01 %
(Sep 30 2015)  


EVH's III. Quarter Q/Q Revenue Comment
Evolent Health Inc achieved in the III. Quarter 2026 below company average Revenue rise of 11.16% quarter on quarter, to $ 725.37 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 7.92% in the III. Quarter a year ago.

Within Internet Services & Social Media industry Evolent Health Inc achieved highest sequential Revenue growth. While Evolent Health Inc 's Revenue growth quarter on quarter, overall rank is 359.


Evolent Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 2,097.02
Y / Y Revenue Growth (TTM) -4.5 %
Year on Year Revenue Growth Overall Ranking # 3083
Seqeuential Revenue Change (TTM) 11.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 3168


Cumulative Revenue growth Comment
Evolent Health Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Evolent Health Inc 's annual Revenue growth would be -4.5% year on year to $2,097 millions.

In the Technology sector 474 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1148 to 3083.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Internet Services & Social Media Industry # 40
Technology Sector # 475
Overall # 3083

Revenue TTM Y/Y Growth Statistics
High Average Low
152.22 %
 25.13 %
-27.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 486
S&P 500 # 3168
Cumulative Revenue growth Comment
Evolent Health Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Evolent Health Inc 's annual Revenue drop would be -4.5% year on year to $2,097 millions.

In the Technology sector 474 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1148 to 3083.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Internet Services & Social Media Industry # 40
Technology Sector # 475
Overall # 3083

Revenue TTM Y/Y Growth Statistics
High Average Low
152.22 %
25.13 %
-27.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 486
S&P 500 # 3168




Other Revenue Growth
Internet Services & Social Media Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EVH's Revenue Growth Ratio versus Internet Services & Social Media Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Technology SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Onto Innovation Inc 88.28%$ 88.283 millions
Celestica Inc 82.57%$ 82.572 millions
Qxo Inc 79.45%$ 79.449 millions
Vicor Corporation78.51%$ 78.508 millions
Paltalk Inc75.54%$ 75.539 millions
Maxlinear Inc 73.20%$ 73.197 millions
Teradyne Inc 69.78%$ 69.778 millions
Actelis Networks Inc68.12%$ 68.118 millions
Firefly Neuroscience Inc 66.75%$ 66.753 millions
Amphenol Corporation65.15%$ 65.147 millions
Imax Corporation64.25%$ 64.252 millions
Monolithic Power Systems Inc63.32%$ 63.320 millions
Vertiv Holdings Co61.18%$ 61.178 millions
Guerrilla RF, Inc.60.56%$ 60.555 millions
Ttm Technologies Inc 59.93%$ 59.931 millions
Arista Networks inc 58.46%$ 58.461 millions
Everspin Technologies Inc 56.35%$ 56.353 millions
Applovin Corporation55.50%$ 55.498 millions
Cerebras Systems Inc.55.33%$ 55.333 millions
Arteris Inc 54.87%$ 54.873 millions
Reddit Inc 53.01%$ 53.007 millions
Innodata inc 52.87%$ 52.867 millions
Hinge Health Inc 52.38%$ 52.381 millions
Evolent Health Inc 51.27%$ 51.265 millions
Ieh Corp51.18%$ 51.182 millions
Fabrinet50.74%$ 50.743 millions
Advanced Energy Industries inc 50.61%$ 50.606 millions
Rank One Computing Corp49.62%$ 49.622 millions
Ultra Clean Holdings Inc 49.06%$ 49.057 millions
Advanced Micro Devices Inc48.86%$ 48.865 millions


About Evolent Health Inc Revenue Growth Rates (EVH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Evolent Health Inc (CIK 1628908).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628908-26-000100
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Evolent Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.